
Stryker Corporation has finalized its acquisition of Amplitude Vascular Systems, a company specializing in next-generation intravascular lithotripsy (IVL) technology for treating complex peripheral arterial disease. This acquisition expands Stryker's peripheral vascular portfolio by integrating AVS's innovative CO₂-generated pressure wave technology, aiming to improve treatment outcomes for challenging arterial conditions. The move positions Stryker to better support physicians and patients with advanced vascular solutions.